Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | ISO | Mustn1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of MUSTN1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | ISO | MUSTN1 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of MUSTN1 mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Mustn1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MUSTN1 mRNA | CTD | PMID:28922406 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MUSTN1 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MUSTN1 mRNA | CTD | PMID:32109520 | 4,4'-sulfonyldiphenol | increases expression | ISO | Mustn1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of MUSTN1 mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Mustn1 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of MUSTN1 exon | CTD | PMID:33297965 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of MUSTN1 mRNA | CTD | PMID:31881176 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of MUSTN1 mRNA | CTD | PMID:28959563 | aflatoxin B1 | decreases expression | ISO | MUSTN1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of MUSTN1 mRNA | CTD | PMID:21641981 | aflatoxin B1 | decreases methylation | ISO | MUSTN1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of MUSTN1 gene | CTD | PMID:27153756 | Aroclor 1254 | increases expression | ISO | Mustn1 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of MUSTN1 mRNA | CTD | PMID:23650126 | atrazine | increases expression | ISO | MUSTN1 (Homo sapiens) | 6480464 | Atrazine results in increased expression of MUSTN1 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | ISO | MUSTN1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of MUSTN1 mRNA | CTD | PMID:21871943 | benzo[a]pyrene | decreases methylation | ISO | MUSTN1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of MUSTN1 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | Mustn1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of MUSTN1 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MUSTN1 mRNA | CTD | PMID:21839799 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | MUSTN1 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of MUSTN1 mRNA | CTD | PMID:31163220 | bisphenol A | increases expression | ISO | Mustn1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of MUSTN1 mRNA | CTD | PMID:26063408 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of MUSTN1 gene | CTD | PMID:28505145 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MUSTN1 mRNA | CTD | PMID:25181051 and PMID:34947998 | butanal | decreases expression | ISO | MUSTN1 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of MUSTN1 mRNA | CTD | PMID:26079696 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of MUSTN1 promoter | CTD | PMID:22457795 | carbon nanotube | increases expression | ISO | Mustn1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | chlordecone | decreases expression | ISO | Mustn1 (Mus musculus) | 6480464 | Chlordecone results in decreased expression of MUSTN1 mRNA | CTD | PMID:33711761 | chloroprene | decreases expression | ISO | Mustn1 (Mus musculus) | 6480464 | Chloroprene results in decreased expression of MUSTN1 mRNA | CTD | PMID:23125180 | chlorpyrifos | increases expression | ISO | Mustn1 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of MUSTN1 mRNA | CTD | PMID:32715474 | choline | multiple interactions | ISO | Mustn1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MUSTN1 mRNA | CTD | PMID:20938992 | cisplatin | increases expression | ISO | MUSTN1 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of MUSTN1 mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | ISO | MUSTN1 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of MUSTN1 mRNA | CTD | PMID:27392435 | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of MUSTN1 mRNA | CTD | PMID:30556269 | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of MUSTN1 mRNA | CTD | PMID:30556269 | corticosterone | increases expression | EXP | | 6480464 | Corticosterone results in increased expression of MUSTN1 mRNA | CTD | PMID:15755911 | decabromodiphenyl ether | affects expression | ISO | MUSTN1 (Homo sapiens) | 6480464 | decabromobiphenyl ether affects the expression of MUSTN1 mRNA | CTD | PMID:24834073 | dibenz[a,h]anthracene | increases expression | ISO | Mustn1 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MUSTN1 mRNA | CTD | PMID:33729688 | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of MUSTN1 mRNA | CTD | PMID:21551480 | dorsomorphin | multiple interactions | ISO | MUSTN1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | increases expression | ISO | MUSTN1 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of MUSTN1 mRNA | CTD | PMID:29803840 | entinostat | decreases expression | ISO | MUSTN1 (Homo sapiens) | 6480464 | entinostat results in decreased expression of MUSTN1 mRNA | CTD | PMID:27188386 | epoxiconazole | increases expression | ISO | Mustn1 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of MUSTN1 mRNA | CTD | PMID:35436446 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of MUSTN1 mRNA | CTD | PMID:24793618 | folic acid | multiple interactions | ISO | Mustn1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MUSTN1 mRNA | CTD | PMID:20938992 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of MUSTN1 mRNA | CTD | PMID:24304932 | genistein | increases expression | ISO | Mustn1 (Mus musculus) | 6480464 | Genistein results in increased expression of MUSTN1 mRNA | CTD | PMID:32186404 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of MUSTN1 mRNA | CTD | PMID:33387578 | isoprenaline | increases expression | ISO | Mustn1 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of MUSTN1 mRNA | CTD | PMID:20003209 | L-methionine | multiple interactions | ISO | Mustn1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MUSTN1 mRNA | CTD | PMID:20938992 | lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of MUSTN1 mRNA | CTD | PMID:22641619 | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of MUSTN1 mRNA | CTD | PMID:26720608 | ozone | multiple interactions | ISO | Mustn1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MUSTN1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MUSTN1 mRNA | CTD | PMID:34911549 | panobinostat | multiple interactions | ISO | MUSTN1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MUSTN1 mRNA | CTD | PMID:27188386 | paracetamol | affects expression | ISO | Mustn1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of MUSTN1 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MUSTN1 mRNA | CTD | PMID:33387578 | perfluorohexanesulfonic acid | increases expression | ISO | Mustn1 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of MUSTN1 mRNA | CTD | PMID:37995155 | phenobarbital | affects expression | ISO | Mustn1 (Mus musculus) | 6480464 | Phenobarbital affects the expression of MUSTN1 mRNA | CTD | PMID:23091169 | phenylephrine | increases expression | EXP | | 6480464 | Phenylephrine results in increased expression of MUSTN1 mRNA | CTD | PMID:18158353 | phenylmercury acetate | multiple interactions | ISO | MUSTN1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MUSTN1 mRNA | CTD | PMID:27188386 | SB 431542 | multiple interactions | ISO | MUSTN1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silver atom | affects expression | ISO | Mustn1 (Mus musculus) | 6480464 | Silver affects the expression of MUSTN1 mRNA | CTD | PMID:27131904 | silver(0) | affects expression | ISO | Mustn1 (Mus musculus) | 6480464 | Silver affects the expression of MUSTN1 mRNA | CTD | PMID:27131904 | sodium arsenite | decreases expression | ISO | Mustn1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of MUSTN1 mRNA | CTD | PMID:37682722 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of MUSTN1 mRNA | CTD | PMID:19281266 | succimer | multiple interactions | ISO | Mustn1 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MUSTN1 mRNA | CTD | PMID:21641980 | tamoxifen | affects expression | ISO | Mustn1 (Mus musculus) | 6480464 | Tamoxifen affects the expression of MUSTN1 mRNA | CTD | PMID:20937368 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of MUSTN1 mRNA | CTD | PMID:34492290 | trichostatin A | increases expression | ISO | MUSTN1 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of MUSTN1 mRNA | CTD | PMID:24935251 | trichostatin A | multiple interactions | ISO | MUSTN1 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MUSTN1 mRNA | CTD | PMID:27188386 | trovafloxacin | increases expression | ISO | Mustn1 (Mus musculus) | 6480464 | trovafloxacin results in increased expression of MUSTN1 mRNA | CTD | PMID:35537566 | valproic acid | affects expression | ISO | MUSTN1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MUSTN1 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | MUSTN1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MUSTN1 mRNA | CTD | PMID:24383497 and PMID:24935251 | valproic acid | multiple interactions | ISO | MUSTN1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MUSTN1 mRNA | CTD | PMID:27188386 | vorinostat | multiple interactions | ISO | MUSTN1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MUSTN1 mRNA | CTD | PMID:27188386 | |